John Smither

John Smither

Director of Finance/CFO at MBX BIOSCIENCES, INC.

Net worth: 353 748 $ as of 30/06/2026

73 year
Health Technology
Commercial Services
Consumer Services

Profile

John William Smither is currently Independent Director at Genelux Corp.
since 2023, Independent Non-Executive Director at NewAmsterdam Pharma Co. NV since 2023, Director at eFFECTOR Therapeutics Operations, Inc. since 2018, Independent Director at Attovia Therapeutics, Inc. starting 2026, Chief Financial Officer at MBX Biosciences, Inc. starting 2026, and a Member of The American Institute of Certified Public Accountants, Financial Executives International, and California Society of Certified Public Accountants.
Former positions include Independent Director at Achaogen, Inc. from 2013 to 2020, Independent Director at Principia Biopharma, Inc. in 2019, Director at Dompe Biotec SpA, Independent Director at eFFECTOR Therapeutics, Inc. from 2018 to 2023, Independent Director at Applied Molecular Transport, Inc. from 2022 to 2023, Vice President-Finance & Administration at Amgen, Inc. from 2001 to 2004, Chief Financial Officer at Kythera Biopharmaceuticals LLC from 2007 to 2015, Audit Partner at Ernst & Young LLP (Missouri), Chief Financial Officer at Amgen Europe BV from 2001 to 2004, Chief Financial Officer at Kite Pharma, Inc. from 2017 to 2018, Chief Financial Officer at Unity Biotechnology, Inc. from 2016 to 2017, Chief Financial Officer at Sienna Biopharmaceuticals, Inc. from 2016 to 2017 and again from 2018 to 2019, Chief Financial Officer at Arcutis Biotherapeutics, Inc. from 2019 to 2021 and from 2023 to 2024.
Education includes undergraduate studies at California State University-Los Angeles.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/07/2026 91,403 ( 0.2% ) 275 123 $ 30/06/2026
15/04/2026 2,320 ( 0% ) 78 625 $ 30/06/2026

John Smither active positions

CompaniesPositionStart
FRAZIER LIFESCIENCES ACQUISITION CORPORATION Director/Board Member 01/01/2023
GENELUX CORPORATION Director/Board Member 11/09/2023
MBX BIOSCIENCES, INC. Director of Finance/CFO 01/03/2026
Director/Board Member 23/03/2018
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member 01/07/2026

Former positions of John Smither

CompaniesPositionEnd
ARCUTIS BIOTHERAPEUTICS, INC. Director of Finance/CFO 10/04/2024
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of John Smither's experience

Training of John Smither

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

59

1st degree connections

22

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies22

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology